ID RAP1_YEAST Reviewed; 827 AA. AC P11938; D6W0X4; DT 01-OCT-1989, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 2. DT 27-MAR-2024, entry version 224. DE RecName: Full=DNA-binding protein RAP1; DE AltName: Full=Repressor/activator site-binding protein; DE AltName: Full=SBF-E; DE AltName: Full=TUF; GN Name=RAP1; Synonyms=GRF1, TUF1; OrderedLocusNames=YNL216W; GN ORFNames=N1310; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=BJ2168; RX PubMed=3315231; DOI=10.1016/0092-8674(87)90095-x; RA Shore D., Nasmyth K.; RT "Purification and cloning of a DNA binding protein from yeast that binds to RT both silencer and activator elements."; RL Cell 51:721-732(1987). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 96604 / S288c / FY1679; RX PubMed=7762305; DOI=10.1002/yea.320110111; RA Coster F., van Dyck L., Jonniaux J.-L., Purnelle B., Goffeau A.; RT "The sequence of a 13.5 kb DNA segment from the left arm of yeast RT chromosome XIV reveals MER1; RAP1; a new putative member of the DNA RT replication complex and a new putative serine/threonine phosphatase gene."; RL Yeast 11:85-91(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169873; RA Philippsen P., Kleine K., Poehlmann R., Duesterhoeft A., Hamberg K., RA Hegemann J.H., Obermaier B., Urrestarazu L.A., Aert R., Albermann K., RA Altmann R., Andre B., Baladron V., Ballesta J.P.G., Becam A.-M., RA Beinhauer J.D., Boskovic J., Buitrago M.J., Bussereau F., Coster F., RA Crouzet M., D'Angelo M., Dal Pero F., De Antoni A., del Rey F., Doignon F., RA Domdey H., Dubois E., Fiedler T.A., Fleig U., Floeth M., Fritz C., RA Gaillardin C., Garcia-Cantalejo J.M., Glansdorff N., Goffeau A., RA Gueldener U., Herbert C.J., Heumann K., Heuss-Neitzel D., Hilbert H., RA Hinni K., Iraqui Houssaini I., Jacquet M., Jimenez A., Jonniaux J.-L., RA Karpfinger-Hartl L., Lanfranchi G., Lepingle A., Levesque H., Lyck R., RA Maftahi M., Mallet L., Maurer C.T.C., Messenguy F., Mewes H.-W., Moestl D., RA Nasr F., Nicaud J.-M., Niedenthal R.K., Pandolfo D., Pierard A., RA Piravandi E., Planta R.J., Pohl T.M., Purnelle B., Rebischung C., RA Remacha M.A., Revuelta J.L., Rinke M., Saiz J.E., Sartorello F., RA Scherens B., Sen-Gupta M., Soler-Mira A., Urbanus J.H.M., Valle G., RA Van Dyck L., Verhasselt P., Vierendeels F., Vissers S., Voet M., RA Volckaert G., Wach A., Wambutt R., Wedler H., Zollner A., Hani J.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIV and its RT evolutionary implications."; RL Nature 387:93-98(1997). RN [4] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [5] RP INTERACTION WITH GCR1. RX PubMed=8508768; DOI=10.1002/j.1460-2075.1993.tb05897.x; RA Tornow J., Zeng X., Gao W., Santangelo G.M.; RT "GCR1, a transcriptional activator in Saccharomyces cerevisiae, complexes RT with RAP1 and can function without its DNA binding domain."; RL EMBO J. 12:2431-2437(1993). RN [6] RP CHARACTERIZATION. RX PubMed=8194531; DOI=10.1002/j.1460-2075.1994.tb06526.x; RA Giraldo R., Rhodes D.; RT "The yeast telomere-binding protein RAP1 binds to and promotes the RT formation of DNA quadruplexes in telomeric DNA."; RL EMBO J. 13:2411-2420(1994). RN [7] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-486, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ADR376; RX PubMed=17330950; DOI=10.1021/pr060559j; RA Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., RA Elias J.E., Gygi S.P.; RT "Large-scale phosphorylation analysis of alpha-factor-arrested RT Saccharomyces cerevisiae."; RL J. Proteome Res. 6:1190-1197(2007). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-731, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [10] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19779198; DOI=10.1126/science.1172867; RA Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.; RT "Global analysis of Cdk1 substrate phosphorylation sites provides insights RT into evolution."; RL Science 325:1682-1686(2009). RN [11] RP X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 360-600. RX PubMed=8620531; DOI=10.1016/s0092-8674(00)81088-0; RA Koenig P., Giraldo R., Chapman L., Rhodes D.; RT "The crystal structure of the DNA-binding domain of yeast RAP1 in complex RT with telomeric DNA."; RL Cell 85:125-136(1996). CC -!- FUNCTION: Essential regulatory protein in yeast whose DNA-binding sites CC are found at three types of chromosomal elements: promoters, silencers, CC and telomeres. RAP1 is also involved in the regulation of telomere CC structure, where its binding sites are found within the terminal CC poly[C(1-3)A] sequences. The opposite regulatory functions of RAP1 are CC not intrinsic to its binding sites but, instead, result from CC interactions with different factors at promoters and silencers. RAP1 CC associates with SIR3 and SIR4 proteins to form a DNA-binding complex CC that initiates the repression at the HM loci and telomeres. May also CC target the binding of RIF1 and RIF2 to silencers and telomeres. Forms CC with GCR1 a transcriptional activation complex that is required for CC expression of glycolytic and ribosomal gene. CC -!- SUBUNIT: RIF1, SIR3 and SIR4 associate with RAP1 C-terminus in vivo. CC Interacts with a GCR1 homodimer. {ECO:0000269|PubMed:8508768}. CC -!- INTERACTION: CC P11938; Q08649: ESA1; NbExp=6; IntAct=EBI-14821, EBI-6648; CC P11938; P03069: GCN4; NbExp=5; IntAct=EBI-14821, EBI-7450; CC P11938; P07261: GCR1; NbExp=2; IntAct=EBI-14821, EBI-7463; CC P11938; P29539: RIF1; NbExp=3; IntAct=EBI-14821, EBI-2083307; CC P11938; Q06208: RIF2; NbExp=5; IntAct=EBI-14821, EBI-15199; CC P11938; P06701: SIR3; NbExp=8; IntAct=EBI-14821, EBI-17230; CC P11938; P11978: SIR4; NbExp=4; IntAct=EBI-14821, EBI-17237; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q96TL7}. CC Chromosome, telomere {ECO:0000250|UniProtKB:Q96TL7}. CC -!- MISCELLANEOUS: Present with 4390 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the RAP1 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M18068; AAA18404.1; -; Unassigned_DNA. DR EMBL; X78898; CAA55491.1; -; Genomic_DNA. DR EMBL; Z71492; CAA96118.1; -; Genomic_DNA. DR EMBL; BK006947; DAA10340.1; -; Genomic_DNA. DR PIR; S50714; S50714. DR RefSeq; NP_014183.1; NM_001183054.1. DR PDB; 1IGN; X-ray; 2.25 A; A/B=353-598. DR PDB; 2L42; NMR; -; A=116-212. DR PDB; 3CZ6; X-ray; 1.85 A; A/B=672-827. DR PDB; 3OWT; X-ray; 2.00 A; A/B=672-827. DR PDB; 3UKG; X-ray; 2.95 A; A=360-601. DR PDB; 4BJ5; X-ray; 3.29 A; C/E=627-827. DR PDB; 4BJ6; X-ray; 3.26 A; C/E=627-827. DR PDB; 4BJT; X-ray; 1.61 A; A/B/C=627-827. DR PDB; 4GFB; X-ray; 2.99 A; A=358-602. DR PDB; 6LDM; X-ray; 2.40 A; A=353-598. DR PDBsum; 1IGN; -. DR PDBsum; 2L42; -. DR PDBsum; 3CZ6; -. DR PDBsum; 3OWT; -. DR PDBsum; 3UKG; -. DR PDBsum; 4BJ5; -. DR PDBsum; 4BJ6; -. DR PDBsum; 4BJT; -. DR PDBsum; 4GFB; -. DR PDBsum; 6LDM; -. DR AlphaFoldDB; P11938; -. DR BMRB; P11938; -. DR SMR; P11938; -. DR BioGRID; 35620; 709. DR ComplexPortal; CPX-1200; RAP1-GCR1 transcription activation complex. DR ComplexPortal; CPX-1229; RAP1-GCR1-GCR2 transcription activation complex. DR ComplexPortal; CPX-2112; Telosome. DR DIP; DIP-851N; -. DR IntAct; P11938; 50. DR MINT; P11938; -. DR STRING; 4932.YNL216W; -. DR iPTMnet; P11938; -. DR MaxQB; P11938; -. DR PaxDb; 4932-YNL216W; -. DR PeptideAtlas; P11938; -. DR EnsemblFungi; YNL216W_mRNA; YNL216W; YNL216W. DR GeneID; 855505; -. DR KEGG; sce:YNL216W; -. DR AGR; SGD:S000005160; -. DR SGD; S000005160; RAP1. DR VEuPathDB; FungiDB:YNL216W; -. DR eggNOG; ENOG502S85C; Eukaryota. DR HOGENOM; CLU_014729_0_0_1; -. DR InParanoid; P11938; -. DR OMA; TENAWRD; -. DR OrthoDB; 1406561at2759; -. DR BioCyc; YEAST:G3O-33222-MONOMER; -. DR BioGRID-ORCS; 855505; 9 hits in 13 CRISPR screens. DR EvolutionaryTrace; P11938; -. DR PRO; PR:P11938; -. DR Proteomes; UP000002311; Chromosome XIV. DR RNAct; P11938; Protein. DR GO; GO:0000781; C:chromosome, telomeric region; IDA:SGD. DR GO; GO:0005829; C:cytosol; IDA:SGD. DR GO; GO:0000228; C:nuclear chromosome; IDA:SGD. DR GO; GO:0005634; C:nucleus; IDA:SGD. DR GO; GO:0032993; C:protein-DNA complex; IMP:CAFA. DR GO; GO:0070187; C:shelterin complex; IDA:SGD. DR GO; GO:0005667; C:transcription regulator complex; IPI:ComplexPortal. DR GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IDA:SGD. DR GO; GO:0008301; F:DNA binding, bending; IDA:SGD. DR GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:SGD. DR GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:SGD. DR GO; GO:0003691; F:double-stranded telomeric DNA binding; IMP:CAFA. DR GO; GO:0051880; F:G-quadruplex DNA binding; IDA:SGD. DR GO; GO:0042393; F:histone binding; IDA:SGD. DR GO; GO:0031492; F:nucleosomal DNA binding; IDA:SGD. DR GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; IDA:SGD. DR GO; GO:0043565; F:sequence-specific DNA binding; HDA:SGD. DR GO; GO:0017025; F:TBP-class protein binding; IDA:SGD. DR GO; GO:0042162; F:telomeric DNA binding; IDA:SGD. DR GO; GO:0001094; F:TFIID-class transcription factor complex binding; IDA:SGD. DR GO; GO:0071169; P:establishment of protein localization to chromatin; IPI:SGD. DR GO; GO:0070200; P:establishment of protein localization to telomere; IPI:SGD. DR GO; GO:0071919; P:G-quadruplex DNA formation; IDA:CACAO. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:SGD. DR GO; GO:0060963; P:positive regulation of ribosomal protein gene transcription by RNA polymerase II; NAS:ComplexPortal. DR GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:SGD. DR GO; GO:0031848; P:protection from non-homologous end joining at telomere; IMP:SGD. DR GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central. DR GO; GO:0006110; P:regulation of glycolytic process; NAS:ComplexPortal. DR GO; GO:0030466; P:silent mating-type cassette heterochromatin formation; IGI:SGD. DR GO; GO:0031509; P:subtelomeric heterochromatin formation; IGI:SGD. DR GO; GO:0000723; P:telomere maintenance; IMP:SGD. DR GO; GO:0010833; P:telomere maintenance via telomere lengthening; IDA:SGD. DR CDD; cd11655; rap1_myb-like; 2. DR CDD; cd11653; rap1_RCT; 1. DR DisProt; DP00020; -. DR Gene3D; 1.10.10.2170; -; 1. DR Gene3D; 1.20.120.1480; -; 1. DR Gene3D; 3.40.50.10190; BRCT domain; 1. DR Gene3D; 1.10.10.60; Homeodomain-like; 2. DR IDEAL; IID50071; -. DR InterPro; IPR001357; BRCT_dom. DR InterPro; IPR036420; BRCT_dom_sf. DR InterPro; IPR009057; Homeobox-like_sf. DR InterPro; IPR017930; Myb_dom. DR InterPro; IPR021661; Rap1_C. DR InterPro; IPR038104; Rap1_C_sf. DR InterPro; IPR015280; Rap1_DNA-bd. DR InterPro; IPR001005; SANT/Myb. DR InterPro; IPR039595; TE2IP/Rap1. DR PANTHER; PTHR16466; TELOMERE REPEAT-BINDING FACTOR 2-INTERACTING PROTEIN 1; 1. DR PANTHER; PTHR16466:SF6; TELOMERIC REPEAT-BINDING FACTOR 2-INTERACTING PROTEIN 1; 1. DR Pfam; PF16589; BRCT_2; 1. DR Pfam; PF00249; Myb_DNA-binding; 1. DR Pfam; PF09197; Rap1-DNA-bind; 1. DR Pfam; PF11626; Rap1_C; 1. DR SMART; SM00292; BRCT; 1. DR SMART; SM00717; SANT; 1. DR SUPFAM; SSF52113; BRCT domain; 1. DR SUPFAM; SSF46689; Homeodomain-like; 2. DR PROSITE; PS50172; BRCT; 1. DR PROSITE; PS51294; HTH_MYB; 1. PE 1: Evidence at protein level; KW 3D-structure; Activator; Chromosome; DNA-binding; Nucleus; Phosphoprotein; KW Reference proteome; Repressor; Telomere; Transcription; KW Transcription regulation. FT CHAIN 1..827 FT /note="DNA-binding protein RAP1" FT /id="PRO_0000197112" FT DOMAIN 121..208 FT /note="BRCT" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00033" FT DOMAIN 355..415 FT /note="HTH myb-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625" FT DNA_BIND 388..411 FT /note="H-T-H motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00625" FT REGION 29..128 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 221..268 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 308..339 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 567..613 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 630..695 FT /note="Activation domain" FT COMPBIAS 31..60 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 61..77 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 78..109 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 226..262 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 594..613 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 486 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:17330950" FT MOD_RES 731 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT CONFLICT 672 FT /note="A -> R (in Ref. 1; AAA18404)" FT /evidence="ECO:0000305" FT HELIX 365..376 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 379..381 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 386..391 FT /evidence="ECO:0007829|PDB:1IGN" FT TURN 392..394 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 400..409 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 412..414 FT /evidence="ECO:0007829|PDB:1IGN" FT STRAND 437..440 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 451..470 FT /evidence="ECO:0007829|PDB:1IGN" FT STRAND 474..476 FT /evidence="ECO:0007829|PDB:1IGN" FT STRAND 509..511 FT /evidence="ECO:0007829|PDB:3UKG" FT HELIX 525..532 FT /evidence="ECO:0007829|PDB:1IGN" FT TURN 533..535 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 538..547 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 549..552 FT /evidence="ECO:0007829|PDB:1IGN" FT HELIX 554..562 FT /evidence="ECO:0007829|PDB:1IGN" FT STRAND 566..568 FT /evidence="ECO:0007829|PDB:6LDM" FT TURN 595..597 FT /evidence="ECO:0007829|PDB:3UKG" FT HELIX 681..684 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 688..690 FT /evidence="ECO:0007829|PDB:4BJT" FT TURN 700..702 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 705..708 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 713..724 FT /evidence="ECO:0007829|PDB:4BJT" FT TURN 730..732 FT /evidence="ECO:0007829|PDB:4BJ6" FT HELIX 733..744 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 748..757 FT /evidence="ECO:0007829|PDB:4BJT" FT TURN 758..760 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 762..764 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 765..775 FT /evidence="ECO:0007829|PDB:4BJT" FT STRAND 781..783 FT /evidence="ECO:0007829|PDB:4BJ6" FT HELIX 789..796 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 800..810 FT /evidence="ECO:0007829|PDB:4BJT" FT HELIX 812..823 FT /evidence="ECO:0007829|PDB:4BJT" SQ SEQUENCE 827 AA; 92413 MW; 67C4AFB03B3C0713 CRC64; MSSPDDFETA PAEYVDALDP SMVVVDSGSA AVTAPSDSAA EVKANQNEEN TGATAAETSE KVDQTEVEKK DDDDTTEVGV TTTTPSIADT AATANIASTS GASVTEPTTD DTAADEKKEQ VSGPPLSNMK FYLNRDADAH DSLNDIDQLA RLIRANGGEV LDSKPRESKE NVFIVSPYNH TNLPTVTPTY IKACCQSNSL LNMENYLVPY DNFREVVDSR LQEESHSNGV DNSNSNSDNK DSIRPKTEII STNTNGATED STSEKVMVDA EQQARLQEQA QLLRQHVSST ASITSGGHND LVQIEQPQKD TSNNNNSNVN DEDNDLLTQD NNPQTADEGN ASFQAQRSMI SRGALPSHNK ASFTDEEDEF ILDVVRKNPT RRTTHTLYDE ISHYVPNHTG NSIRHRFRVY LSKRLEYVYE VDKFGKLVRD DDGNLIKTKV LPPSIKRKFS ADEDYTLAIA VKKQFYRDLF QIDPDTGRSL ITDEDTPTAI ARRNMTMDPN HVPGSEPNFA AYRTQSRRGP IAREFFKHFA EEHAAHTENA WRDRFRKFLL AYGIDDYISY YEAEKAQNRE PEPMKNLTNR PKRPGVPTPG NYNSAAKRAR NYSSQRNVQP TANAASANAA AAAAAAASNS YAIPENELLD EDTMNFISSL KNDLSNISNS LPFEYPHEIA EAIRSDFSNE DIYDNIDPDT ISFPPKIATT DLFLPLFFHF GSTRQFMDKL HEVISGDYEP SQAEKLVQDL CDETGIRKNF STSILTCLSG DLMVFPRYFL NMFKDNVNPP PNVPGIWTHD DDESLKSNDQ EQIRKLVKKH GTGRMEMRKR FFEKDLL //